Test to allow doctors to determine best breast cancer treatment

Test to allow doctors to determine best breast cancer treatment

A breast cancer test has been developed to determine the best treatment for breast cancer patients.

Scientists at Queen Mary University of London have developed the test, according to a study published in Breast Cancer Research and Treatment.

The research finds that the EndoPredict (Myriad Genetics) test can assess whether chemotherapy would be the best course of action for a patient, as those with a high risk of metastasis would be directed to chemotherapy whereas those with lower risk would be able to opt out of the treatment.

Published: by Radio NewsHub
Start your relationship

If you are interested in receiving bulletins from Radio News Hub or would simply like to find out more please fill in the form below.

We aim to get back to you within 48 hours